GenoMe Diagnostics develops OvaME product that helps in improvement of status quo of CA125 blood tests.
GenoMe Diagnostics has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
GenoMe Diagnostics's investors include Innovate UK, Deepbridge Capital, QUBIS, Co-FundNI.
GenoMe Diagnostics is headquartered in Belfast, United Kingdom.
GenoMe Diagnostics develops OvaME product that helps in improvement of status quo of CA125 blood tests.
GenoMe Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GenoMe Diagnostics — Funding & Investors." VCBacked, March 3, 2023, https://www.vcbacked.co/company/genome-diagnostics. Accessed November 15, 2026.
VCBacked. (2023). GenoMe Diagnostics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/genome-diagnostics
{{cite web |title=GenoMe Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/genome-diagnostics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at GenoMe Diagnostics? Request a listing update